Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...

Fintel reports that on November 11, 2024, Stifel downgraded their outlook for Tempus AI (NasdaqGS:TEM) from Buy to Hold. ...

周二，Piper Sandler调整了对Tempus AI Inc (NASDAQ:TEM)的展望，将该人工智能公司的股票目标价从此前的40美元上调至70美元。该公司维持对Tempus AI股票的中性评级。此次调整是在Tempus AI最近发布财报后做出的，财报是修订估值的一个因素。 Piper Sandler的分析师将财报作为上调目标价的主要原因。尽管做出了积极调整，但分析师指出，新的目标价并未 ...

Stifel Nicolaus analyst Daniel Arias downgraded the rating on Tempus AI, Inc. Class A (TEM – Research Report) to a Hold yesterday, ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Thank you for standing by. My name is Briana, and I will be your conference operator today. At this time, I’d like to welcome everyone to ...

周一，金融服务公司Stifel调整了对Tempus AI Inc (NASDAQ:TEM)的立场，将该股评级从买入下调至持有。该公司将新的目标价设定为65.00美元，高于此前的45.00美元。这一决定是在Tempus AI股票自6月首次公开发行(IPO)以来经历了显著波动之后做出的。 自市场首次亮相以来，Tempus AI的股票已经上涨了约100%。根据Stifel的分析，该公司的估值现在远高于其 ...

Aliso Viejo-based Ambry Genetics Corp. on Nov. 4 announced an agreement to be acquired for $600 million by Tempus AI Inc.

As of November 08, 2024, Tempus AI, Inc had a $11.6 billion market capitalization, putting it in the 82nd percentile of companies in the Life Sciences Tools & Services industry. Tempus AI, Inc does ...

The firms said that the deal will provide access to Tempus' testing menu for healthcare providers at 800 cancer care locations that use Flatiron's OncoEMR platform.

Our Tempus AI Inc share price forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Tempus AI share price predictions. View ...